Alnylam Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R.
ALNY Key Statistics
Stock Snapshot
With a market cap of 43.61B, Alnylam Pharmaceuticals(ALNY) trades at $328.73. The stock has a price-to-earnings ratio of 141.12.
As of 2026-04-02, Alnylam Pharmaceuticals(ALNY) stock has fluctuated between $327.59 and $335.48. The current price stands at $328.73, placing the stock +0.3% above today's low and -2.0% off the high.
The Alnylam Pharmaceuticals(ALNY)'s current trading volume is 662.39K, compared to an average daily volume of 1.19M.
In the last year, Alnylam Pharmaceuticals(ALNY) shares hit a 52-week high of $495.55 and a 52-week low of $205.87.
In the last year, Alnylam Pharmaceuticals(ALNY) shares hit a 52-week high of $495.55 and a 52-week low of $205.87.
ALNY News
Alnylam Pharmaceuticals has reported new clinical and real world data on its RNAi therapy vutrisiran in ATTR-CM, highlighting durable benefits in quality of lif...
Alnylam Pharmaceuticals (ALNY) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, shar...
Alnylam (ALNY) presented pooled Phase 2 safety data for zilebesiran, an investigational RNAi therapeutic being evaluated for cardiovascular risk reduction in pa...
Analyst ratings
71%
of 28 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.